Patients with brain injury and mechanical ventilation exposed to extubation/tracheostomy
OtherExtubation and/or tracheostomy if applicable
NCT Number: NCT03400904
Rationale Prolonged mechanical ventilation (MV) is common in patients with severe Brain Injury (BI). Guidelines for the management of extubation are largely lacking for patients with BI, and the role of tracheostomy is highly uncertain. More important, data on practice of management of extubation is yet underreported, as is the use of tracheotomy in this specific subset of critical care patients.
Objective The objective of this prospective observational study is to describe the management of extubation and tracheostomy in intensive care unit (ICU) patients with BI. The aim is to describe the incidence of extubation failure and the rate of tracheostomy.
Study design The "Extubation strategies in Neuro-Intensive care unit patients, and associations with Outcomes (ENIO)" is an observational multicentre international cohort study.
Study population The investigators will include patients undergoing BI, with an initial Glasgow Coma Score ≤ 12 and with a delivered duration of mechanical ventilation (MV) ≥ 24 hours at ICU admission. The inclusion period will last 6 months in total, and each centre is expected to include at least 24 patients during this period. With over 60 ICUs participating worldwide, we expect to include 1500 patients.
Main parameters Parameters to be collected include: general neurological management, ventilatory management, general ICU complications, specific data on extubation and tracheostomy, general in-ICU outcomes and in-hospital mortality.
Nature and extent of the burden and risks associated with participation Because of the observational design of the study using routinely collected data, there is no additional burden for the patient. Collection of data from ICU charts and/or (written or electronic) medical records systems bears no risk to the patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nantes University Hospital, Nantes, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extubation and/or tracheostomy if applicable
Time frame: Extubation failure will be defined as the need to re-intubate the patient within 48hours after removal
Successful removal of endo-tracheal tube
Time frame: Extubation failure will be defined as the need to re-intubate the patient within 96hours after removal
Successful removal of endo-tracheal tube
Time frame: Extubation failure will be defined as the need to re-intubate the patient within 168hours (7 days) after removal
Successful removal of endo-tracheal tube
Time frame: Onset of VAP during ICU stay and after extubation failure, when appropriate (Median 15 days)
Ventilator-acquired pneumonia (VAP)
Time frame: ICU-stay (Median 15 days)
Calculation of the duration of Mechanical Ventilation during ICU stay.
Time frame: ICU stay (Median 15 days)
Study the rate and reasons for tracheostomy in patients with brain injury
Time frame: During ICU stay (Median 15 days)
Death in the ICU
Time frame: During the first hospital stay following Brain-Injury (Median 25 days)
Death during hospitalization
Nantes University Hospital
Other
Gestion du Sevrage de la Ventilation mécanique du Patient neurolésé en réanimation et Association Avec le Devenir. Etude Observationnelle Multi-centrique Internationale. Extubation Strategies in Neuro-Intensive Care Unit Patients and Associations With Outcome. The International Observational ENIO Study.
Acronym: ENIO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01899924
Brain Diseases, Brain Injuries
Limoges, France
View Trial DetailsNCT05287542
Brain Diseases, Brain Injuries
Nesoddtangen, Akershus, Norway
View Trial DetailsNCT06661980
Brain Diseases, Brain Injuries
Damanhūr, Elbehairah, Egypt
View Trial DetailsNCT03512054
Brain Diseases, Brain Injuries
Bordeaux, France
View Trial Details